UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnings in Q2, helped by favorable reserve developments. However, membership in Medicare Advantage plans is declining, with an expected loss of about 1.1 million members in 2026 as UnitedHealth and peers reduce offerings due to rising care costs. Maintaining Medicare Advantage profit margins above 3% remains a key challenge amid industry pressures.
UnitedHealth Group shares are trading at USD 373.10 on Pluang as of Oct 08, 2026 20:42 WIB, down 0.77% for the day. The stock's market capitalization stands at $337.48 billion, reflecting its significant scale in the health sector. Trading volume reached 5,620,541 shares, with investor activity evenly split between buying and selling at this time.
Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...
UnitedHealth Group's stock has risen from $300 to around $440-$450, reflecting a recovery in margins and key business areas like Medicare Advantage and Optum Health. However, the current valuation leaves little room for safety, as the market already ...
UnitedHealth Group (UNH) is rated a Buy as its fundamentals improve and its price-to-earnings ratio hits a decade low at 19.95, despite being cheaper than peers. Key focus areas for Q3 include commercial cost trends, star ratings, cash flow guidance,...
